<DOC>
	<DOCNO>NCT01704417</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare effect exercise blood glucose subject type 1 diabetes , treat either insulin degludec ( IDeg ) insulin glargine ( IGlar ) .</brief_summary>
	<brief_title>A Trial Comparing Effect Exercise Blood Glucose Subjects With Type 1 Diabetes , Who Are Treated With Either Insulin Degludec Insulin Glargine</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 1 diabetes mellitus ( diagnose clinically ) least 12 month Body mass index 18.027.0 kg/m^2 ( inclusive ) Subjects perform regular physical cardiorespiratory activity Glycosylated haemoglobin ( HbA1c ) equal 9.5 % Subject donate blood plasma past month 500 mL within 3 month prior screen Smoker ( define subject smoke 5 cigarette equivalent per day ) Not able willing refrain smoking use nicotine substitute product inpatient period Supine blood pressure screening ( rest least 5 minute ) outside range 90140 mmHg systolic 5090 mmHg diastolic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>